logo
episode-header-image
Feb 2023
22m 9s

Episode 219: ASCO GU 2023: Neeraj Agarwa...

THE UROMIGOS
About this episode

Neeraj Agarwal, MD, FASCO, describes the data from the TALAPRO-2 study on combination talazoparib and enzalutamide for metastatic castration-resistant prostate cancer as presented at the 2023 ASCO GU Cancers Symposium. Dr. Agarwal is a medical oncologist and Presidential Endowed Chair at Huntsman Cancer Institute, as well as editor-in-chief for ASCO Daily News.

Up next
Yesterday
Episode 436: The History of IO in RCC - Part 2
We continue our conversation with Mike Atkins and David McDermott, discussing IO-based combination therapy in RCC. 
36m 29s
Aug 18
Episode 435: The History of IO in RCC - Part 1
The fathers of IO therapy in RCC - Michael Atkins and David McDermott - join us to take a tour through IO development in RCC over the last 20 years. 
27m 52s
Aug 4
Episode 434: IMPACT series - A Walk Through the History of VEGF TKI Development in RCC
Danny Heng joins to tour through VEGF TKI drug development from sorafenib to tivozanib and everything in between. 
48m 51s
Recommended Episodes
Jun 2023
Highlights From the 2023 American Society of Clinical Oncology Annual Meeting
JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting’s Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute. Related Content: Highlights ... Show More
21m 41s
May 2024
Highlights From the American Head and Neck Society Annual Meeting at COSM 2024
Combined Otolaryngology Spring Meetings Chair Patrick Ha, MD, and Co-Chairs Nicole C. Schmitt, MD, and Sidharth V. Puram, MD, PhD, share late-breaking research from the annual Combined Otolaryngology Spring Meetings in an interview hosted by JAMA Otolaryngology Web Editor Paul C. ... Show More
18m 51s
Feb 2024
Lung Cancer Screening with Low Dose CT
Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke an ... Show More
36m 43s
Dec 2022
Management of Gallbladder Polyps.
Dr. Refky Nicola discusses the Society of Radiologists in Ultrasound Consensus Conference recommendations on management of incidentally detected gallbladder polyps with Dr. Paul Sidhu. Management of Incidentally Detected Gallbladder Polyps: Society of Radiologists in Ultrasound C ... Show More
11m 37s
Jan 2024
215. PERSPECTIVES POUR 2024 DANS LE CANCER DE PROSTATE MÉTASTATIQUE - PROFESSEUR FIARD
215. PERSPECTIVES POUR 2024 DANS LE CANCER DE PROSTATE MÉTASTATIQUE - PROFESSEUR FIARDQuelles perspectives pour le traitement du cancer de la prostate hormonosensible ?Quelles perspectives 2024 au stade de résistance à la castration ?Quelles questions restent en suspens en ce déb ... Show More
7m 27s
Feb 2024
New 2024 Guidelines: Corticosteroids in Sepsis, ARDS, and CAP
This episode delves into the 2024 update on corticosteroid guidelines for critically ill patients with sepsis, ARDS, and community-acquired pneumonia. We break down the recommendations, evidence, and clinical implications of this crucial guidance for healthcare providers. The Vas ... Show More
6m 51s
Nov 2021
Issue Summary 2: November 2021
Dr. Refky Nicola interviews Dr. Joshua Solomon and Dr. David Lynch. CT of Post-Acute Lung Complications of COVID-19. Solomon et al. Radiology 2021; 301:E383–E395.  Introduction by Dr. Linda Chu 
11m 47s
Jul 2023
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.2
Dr. Navneet Singh highlights the latest evidence-based recommendation updates from the ASCO living guideline on stage IV non-small cell lung cancer with driver alterations. This update focuses on new second-line options for patients with advanced NSCLC and an EGFR exon 20 inserti ... Show More
7m 30s